Reid G. Adler Vista Gen Therapeutics, Inc. (VTGN) insider trading activity

VTGN Quotes by TradingView

Reid G. Adler is CHF CORP DEVEL OFF, GEN COUNS of VistaGen Therapeutics, Inc.. Currently has a direct ownership of 16,509 shares of VTGN, which is worth approximately $46,390. The most recent transaction as insider was on Jun 28, 2024, when has been sold 4,854 shares (Common Stock) at a price of $2.96 per share, resulting in proceeds of $14,367. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K
0% 3M change
41.65% 12M change
Total Value Held $46,390

Reid G. Adler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 28 2024
BUY
Grant, award, or other acquisition
$14,367 $2.96 p/Share
4,854 Added 22.72%
16,509 Common Stock
Dec 29 2023
BUY
Grant, award, or other acquisition
$287 $1.72 p/Share
167 Added 1.41%
11,655 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
$265 $1.59 p/Share
167 Added 1.43%
11,488 Common Stock
Aug 17 2022
BUY
Open market or private purchase
$51,000 $0.17 p/Share
300,000 Added 47.27%
334,629 Common Stock
RGA

Reid G. Adler

CHF CORP DEVEL OFF, GEN COUNS
South San Francisco, CA

Track Institutional and Insider Activities on VTGN

Follow VistaGen Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTGN shares.

Notify only if

Insider Trading

Get notified when an Vista Gen Therapeutics, Inc. insider buys or sells VTGN shares.

Notify only if

News

Receive news related to VistaGen Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VTGN